Etid klinik pou Lupus nan Georgia
9 etid pou Lupus ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Parris and Associates Rheumatology, Lawrenceville
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT06133972A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Atlanta Research Center for Rheumatology, Marietta
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07438496A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Emory University School of Medicine, Atlanta
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Atlanta
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50566, Gainesville
- Sl0044 50659, Marietta
Ap rekriteFaz 3
Laj 16 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06617325A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0069, Atlanta
Ap rekriteEtid obsèvasyon
Laj 16 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Emory University, Atlanta
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Emory University School of Medicine, Atlanta
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05799378Lupus Landmark Study: A Prospective Registry and Biorepository
- Emory University, Atlanta
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.